Telbivudine
id:
telbivudine-323-18624073
title:
Telbivudine
text:
Telbivudine is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Swiss pharmaceutical company Novartis under the trade names Sebivo and Tyzeka. Clinical trials have shown it to be significantly more effective than lamivudine or adefovir, and less likely to cause resistance. However, HBV signature resistance mutation M204I or L180M+M204V have been associated with Telbivudine resistance. Telbivudine is a synthetic thymidine β-L-nucleoside analogue; it is the L-iso
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Telbivudine
date created:
date modified:
2024-02-11T02:28:43Z
main entity:
{"identifier":"Q413621","url":"https://www.wikidata.org/entity/Q413621"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/5/5b/Telbivudine_structure.svg","width":512,"height":558}
fields total:
13
integrity:
15